Steven Lo, Vaxart CEO
Vaxart shares surge on norovirus vaccine data as it seeks funding for new trials
A small vaccine maker’s stock price shot up Wednesday after releasing new data in the same week that vaccine R&D is the focus of attention …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
